Even the recent medicare prescription coverage that just passed really serves to benefit pharmaceutical companies.
If you havn't been to
www.nofreelunch.org than go!!!! Here is some VERY interesting things from that site:
"Pharmaceutical Facts
The “Research-based” pharmaceutical industry spends more on marketing and administration than it does on research and development. (Families USA)
U.S. Drug spending increased 17.1% to $154.5 billion dollars in 2001. One-quarter of this increase was due to a shift to the use of more expensive drugs. (National Institute for Health Care Management)
The top selling drug in 2001 was Lipitor. Increase in Lipitor sales contributed more than any other single drug to the increase in drug costs that year (NIHCM). The effect of Lipitor on cardiovascular morbidity and mortality remains unknown.
Pharmaceutical industry profits were 18.5% of revenue in 2001. For the remainder of Fortune 500 companies, median profits were 3.5% (FamiliesUSA).
Since 1995, R&D staff of U.S. brand name drug companies have decreased by 2%, while marketing staff have increased by 59%. Currently, 22% of staff are employed in research and development, while 39% are in marketing. (PhRMA Industry Profile 2000; percentages calculated by Sager and Socolar)
In a study by Avorn, et al, forty-six per-cent of physicians reported that drug reps are moderately to very important in influencing their prescribing habits (Am Journal of Med, 1982).
In a study by Lurie, et al, one-third of medical residents reported that they change their practice based on information provided by drug reps (Journal of Gen Int Med, 1990).
In a study by Steinman, et al, 61% of medical residents stated that industry promotions did not influence their own prescribing, but only 16% believed other physicians to be similarly uninfluenced.(Am Journal of Med, 2000)
Two and one-half billion dollars were spent on advertising to consumers in 2000. Increases in the sales of the 50 drugs most heavily advertised to consumers were responsible for almost half (47.8%) of the $20.8 billion increase in spending in 2000.(NIHCM)
In 2000, Merck spent $161 million on advertising for Vioxx. That is more than Pepsico spent advertising Pepsi. ($125 million), and more than Anheuser-Busch spent advertising Budweiser.($146 million). The increase in Vioxx sales in 2000 accounted for 5.7% of the 1 year increase in drug spending. (NIHCM)
A study by Westfall, et al, found that 96% of physicians and staff had taken samples for personal or family use in the preceding year. (JAMA, 1997)
According to industry estimates, drug companies spent $15.7 billion dollars on promotion in 2000. $7.2 billion dollars worth of free samples were distributed that year(IMS Health).
A study by Chew, et al , found that in the treatment of hypertension, over 90% of physicians would dispense a sample that differed from their preferred drug choice. (JGIM, 2000)
The AMA generates $20 million in annual income by selling detailed personal and professional information on all doctors practicing in the United States to the pharmaceutical industry (NY Times, November 16, 2000).
Submit your facts
(with references)
--------------------------------------------------------------------------------
Fallacies in Pharmaceutical Promotion
(J Gen Int Med, 1994)
Argumentum ad Verecundiam (appeal to authority)
"Doctor, The Chairman of I.D. here says he's using TrovanTM for all his UTI patients; don't you think you should try it?"
Argumentum ad Populum (the bandwagon effect)
"Doctor, everyone over at University is using TrovanTM; don't you think you should?"
Oh and did I mention the FDA advisory . . .
Non Sequitur (the red herring)
"Yes it's true, doctor, that endoscopic ulcerations don't necessarily correlate with symptomatic ulcers, but nevertheless . . ."
Argumentum ad Misericordiam (appeal to pity)
"Doctor, Nexium just has not been doing well in my territory. Do you think you might try it?
and we add:
Post prandium ergo propter prandium
(After lunch, therefore, because of lunch)
The tendency to prescribe a medication following a drug company lunch. In the case of a breakfast, referred to as "bagel bias." "
Nursing News